<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Neoadjuvant <z:e sem="disease" ids="C1559154" disease_type="Disease or Syndrome" abbrv="">chemoradiation</z:e> is the standard treatment for advanced <z:e sem="disease" ids="C1527408,C0034885" disease_type="Disease or Syndrome;Neoplastic Process" abbrv="">rectal tumor</z:e>, providing better local control of disease and potentially increasing sphincter preservation surgery </plain></SENT>
<SENT sid="1" pm="."><plain>Neoadjuvant radiation may affect the number of lymph nodes harvested after resection or alter their prognostic value </plain></SENT>
<SENT sid="2" pm="."><plain>Over the past 10 years, standards for lymph node harvests in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> have been proposed </plain></SENT>
<SENT sid="3" pm="."><plain>Several studies have recommend examination of at least 12 lymph nodes (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LNs</z:e>) in the specimen and this number is now used as a reflection of surgical quality </plain></SENT>
<SENT sid="4" pm="."><plain>Nevertheless, recent reports have identified significantly decreased <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e> harvests in patients treated with neoadjuvant radiation </plain></SENT>
<SENT sid="5" pm="."><plain>And preoperative <z:e sem="disease" ids="C1559154" disease_type="Disease or Syndrome" abbrv="">chemoradiation</z:e> has a significant effect on the number of nodes harvested in rectal specimens and this should be considered in staging of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>In the near future, the total number of nodes will be less important than specific biologic markers in detecting high-risk patients and improving their prognosis with adjuvant therapy tailored </plain></SENT>
</text></document>